The biotech industry is important for the creation of new drugs, job growth, and the health of the overall economy, but companies in this sector have continually found it challenging to raise the money they need to operate, says biopharmaceutical investment professional Mark Kessel in The Scientist. One solution, he says, would be for big pharma to create a biotech fund that utilizes pharma's cash to support biotech where needed.